Although neither BEX1 nor BEX4 expression was significantly related to the survival of patients with GBM (data not shown, n = 220), a high expression of BEX1 or BEX4 in proneural GBM marginally reduced the median survival of patients (Figure 1F). The gene discussed is BEX1; the disease is glioblastoma.